Lesaka Beats Earnings, But Buy-And-Hold Still Wins

Lesaka Technologies(LSAK), ranking by market capitalization reported its fiscal 2026 Q4 earnings on Sep 09th, 2026. The company delivered a significant beat on both top and bottom lines, with Non-GAAP EPS of $0.39 surpassing estimates by $0.05. Full-year revenue also exceeded expectations, contributing to a strong return to profitability. Management provided upbeat guidance for the upcoming fiscal year, signaling continued operational improvements.

Revenue

The total revenue of Lesaka Technologies increased by 11.8% to $188.32 million in 2026 Q4, up from $168.47 million in 2025 Q4 .

Earnings/Net Income

Lesaka Technologies returned to profitability with EPS of $0.04 in 2026 Q4, reversing from a loss of $0.39 per share in 2025 Q4 (109.7% positive change). Meanwhile, the company achieved a remarkable turnaround with net income of $3.22 million in 2026 Q4, representing a 110.2% positive swing from the net loss of $-31.48 million in 2025 Q4. The strong EPS performance indicates a successful operational turnaround and effective cost management strategies.

Price Action

The stock price of Lesaka Technologies has edged up 0.22% during the latest trading day, has edged up 2.68% during the most recent full trading week, and has dropped 6.13% month-to-date.

Post-Earnings Price Action Review

I'll run this under your standing earnings-event backtest playbook, adapted to the revenue-drop-QoQ trigger: entry at release-day close, exit at close 30 trading days later, 3-year sample, full event table plus win rate / mean / median / compounded return, benchmarked against all-release baseline and buy-and-hold. First I need LSAK's daily price history and its quarterly revenue figures with release dates.Now I'll fetch LSAK's quarterly revenue data with fiscal quarter end dates and report release dates, covering the 3-year backtest window.Revenue ladder retrieved — 14 report-end-aligned quarters (Lesaka's fiscal year ends June 30; quarters are contiguous Mar/Jun/Sep/Dec), with release dates from 2023-05-09 through 2026-09-09. Notably, the quarter ended 2026-06-30 was released today (2026-09-09). To complete QoQ/YoY bases for the earliest in-window events and to build the price-side of the backtest, I'll now fetch the pre-window quarters (2022) and LSAK's daily OHLC prices, and verify today's release via search in parallel.Verified from search: Lesaka released its Q4 & FY2026 results after market close today (2026-09-09) (webcast on Sep 10) — so that quarter's event window is open/unclosed and will be flagged and excluded from the aggregate stats per the playbook. Extended-hours print showed ~+5.4%. Now let me inspect the saved price artifact so I can compute the event returns.Data is complete: 780 trading days of OHLC (2023-08-01 → 2026-09-09), no missing closes, plus 19 quarters of revenue (2022-03-31 → 2026-06-30) with verified release dates. Now I'll check the skill's calculation conventions before running the event-study computation.Data is all in place (780 sessions of OHLC, 19 quarters of revenue with release dates). Now I'll run the deterministic event-study calculation per the playbook: revenue-drop-QoQ trigger → next-session-close entry → 30-trading-day hold.The calculation is complete. Per your visualization preference I'll anchor the analysis with a 3-year LSAK candlestick plus a per-event returns chart — loading the visualization skill now.Candlestick rendering completed. Now rendering the per-event returns bar chart with the computed data (12 closed events, trigger events marked with an asterisk).Backtest complete. Here are the results.

Verdict: mild positive tilt, but far too few signal events to call it an edge — treat as "Watch", not "proven"

Over the past 3 years, "buy LSAK after a quarter-over-quarter revenue decline" fired only 3 times. Those 3 trades produced a 66.7% win rate, +2.80% mean 30-day return, and +8.15% compounded — better than buying after every earnings release (50% win rate, +0.27% mean, −2.81% compounded), but materially behind simply holding the stock (+22.07% over the same window). With n=3, this is a pattern worth tracking, not a statistically reliable edge.

Backtest rules (per your standing earnings-event playbook, adapted to this trigger)

• Trigger: quarter-over-quarter revenue decline identified at the earnings release, using the vendor's report-end-aligned quarterly revenue (Lesaka's fiscal year ends June 30, so all quarters are contiguous calendar quarters)

• Entry: close of the first trading session after the release (11 of 13 in-window releases were after U.S. market close, so this is entry T+1; strictly avoids same-day availability and overnight-gap ambiguity)

• Exit: close 30 trading days after entry; window covers releases from 2023-09-12 to 2026-05-06; the 2026-09-09 event is open/unclosed today and excluded from aggregate stats

• Price basis: 780 trading sessions of daily closes, 2023-08-01 → 2026-09-09

The 3 trigger events

| Fiscal Q end | Release date | Revenue QoQ (%) | Entry date | Entry price (USD) | Exit date | Exit price (USD) | 30-day return (%) |

|---|---|---|---|---|---|---|---|

| 2023-06-30 | 2023-09-12 | -0.61 | 2023-09-13 | 3.95 | 2023-10-25 | 4.37 | +10.63 |

| 2024-03-31 | 2024-05-08 | -3.96 | 2024-05-09 | 4.80 | 2024-06-24 | 4.83 | +0.63 |

| 2025-03-31 | 2025-05-07 | -8.38 | 2025-05-08 | 4.21 | 2025-06-23 | 4.09 | -2.85 |

Strategy performance vs. benchmarks

Derived-split row is my arithmetic from the same event ledger; all other figures come from the backtest calculation .

| Sample | Events | Win rate (%) | Mean 30d (%) | Median 30d (%) | Compounded (%) |

|---|---|---|---|---|---|

| Trigger strategy (revenue-down QoQ) | 3 | 66.7 | 2.80 | 0.63 | 8.15 |

| All earnings releases (baseline) | 12 | 50.0 | 0.27 | -0.62 | -2.81 |

| Revenue-growth releases (derived split) | 9 | 44.4 | -0.57 | -1.87 | -10.11 |

| Buy-and-hold (2023-08-01 → 2026-09-09) | — | — | — | — | +22.07 total / +6.66 ann. |

Full event ledger behind the averages — note that the two worst 30-day outcomes both came from revenue-growth releases, while revenue-drop entries clustered in a mild range:

| Fiscal Q end | Release date | QoQ (%) | Trigger | 30d return (%) |

|---|---|---|---|---|

| 2023-06-30 | 2023-09-12 | -0.61 | Yes | +10.63 |

| 2023-09-30 | 2023-11-07 | +2.21 | No | -22.09 |

| 2023-12-31 | 2024-02-06 | +5.73 | No | -1.87 |

| 2024-03-31 | 2024-05-08 | -3.96 | Yes | +0.63 |

| 2024-06-30 | 2024-09-11 | +5.68 | No | +11.81 |

| 2024-09-30 | 2024-11-06 | +5.15 | No | -6.52 |

| 2024-12-31 | 2025-02-05 | +14.75 | No | -5.19 |

| 2025-03-31 | 2025-05-07 | -8.38 | Yes | -2.85 |

| 2025-06-30 | 2025-09-10 | +4.35 | No | +4.00 |

| 2025-09-30 | 2025-11-05 | +1.77 | No | +6.75 |

| 2025-12-31 | 2026-02-04 | +4.25 | No | +15.18 |

| 2026-03-31 | 2026-05-06 | +2.42 | No | -7.24 |

| 2026-06-30 | 2026-09-09 | +2.88 | No | open |

The chart below plots those 12 closed events; starred dates are the trigger entries.

Reading it: the −22.1% outlier (Nov 2023) and the −7.2% (May 2026) were both growth-quarter entries, so the averaging edge of the "bad news already sold off" trigger comes mostly from avoiding disaster entries as much as from positive drift after dips. Also note the worst trigger entry (May 2025, −8.38% QoQ) fell −8.2% on release day itself, so the T+1-close entry already absorbed most of that damage before the holding window even started .

For price context over the backtest window:

LSAK went from $3.76 (2023-08-01) to $4.59 (2026-09-09), +22.1% — a slow grind rather than a trend, which is exactly why event-timing rules matter more than direction here.

Relevance to today

Lesaka released its FY2026 fourth-quarter results (quarter ended 2026-06-30) after the U.S. close today, September 9, 2026, with the webcast scheduled for September 10 . Revenue printed $188.32M, +2.88% QoQ — a growth quarter, so no trigger fires under your rule; the stock traded around +5.4% in extended hours . This event's 30-day window opens with the next session but is deliberately left out of the stats above.

Caveats and next steps

• Sample size is the whole story: 3 triggers in 3 years (~1/year). Even taken at face value, +2.8% per event compounds to roughly +2.8% annualized — below buy-and-hold's +6.66%. The rule's current value is as a filter against bad entries, not a standalone return engine.

• Revenue figures use the vendor's report-end-aligned revenue series ; release dates are vendor-supplied and match Lesaka's IR release pattern, but a single misdated release would drop the sample to 2 — another reason to hold this loosely.

• These are point-in-time backtest results, not a prediction; do not size real money on a 3-event sample. If you want to develop it further, the highest-information next step is extending the same backtest to alternative hold lengths before adding capital.

suggestion

Backtest the reverse trigger: buying after revenue-growth quarters with the same 30-day hold

Rerun this with 10-day and 60-day holds to see if the edge is holding-period sensitive

Notify me when Lesaka's next quarterly report date is announced

Guidance

For FY2027, the year ending June 30, 2027, we expect: Net Revenue between ZAR 7.0 billion and ZAR 7.7 billion Group Adjusted EBITDA between ZAR 1.45 billion and ZAR 1.60 billion Adjusted earnings per share between ZAR 7.50 and ZAR 8.50 For Q1 FY2027, the quarter ending September 30, 2026, we expect: Net Revenue between ZAR 1.58 billion and ZAR 1.66 billion Group Adjusted EBITDA between ZAR 200 million and ZAR 240 million Adjusted earnings per share between ZAR 0.40 and ZAR 0.60

Additional News

Lesaka Technologies recently concluded a comprehensive brand refresh initiative, launching the "One Lesaka" consolidation strategy in November 2025. This restructuring effort involved significant one-off rebrand costs incurred during the fiscal year 2026, aimed at streamlining operations and enhancing market presence. The company has also highlighted strategic ambitions to achieve a greater than 40% compound annual growth rate in Adjusted EPS over the next three years. Additionally, Lesaka continues to navigate currency fluctuations by reporting performance in South African Rand (ZAR) while providing USD-denominated financial results. No major M&A activities or C-level executive changes were reported in the immediate vicinity of the earnings release.